These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 37599536)

  • 1. Longitudinal Changes in Neuropsychological Functioning in Japanese Patients with Myotonic Dystrophy Type 1: A Five Year Follow-Up Study.
    Fujino H; Suwazono S; Ueda Y; Kobayashi M; Nakayama T; Imura O; Matsumura T; Takahashi MP
    J Neuromuscul Dis; 2023; 10(6):1083-1092. PubMed ID: 37599536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age-related cognitive decline in myotonic dystrophy type 1: An 11-year longitudinal follow-up study.
    Labayru G; Aliri J; Zulaica M; López de Munain A; Sistiaga A
    J Neuropsychol; 2020 Mar; 14(1):121-134. PubMed ID: 31407859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive impairment in myotonic dystrophy type 1 (DM1): a longitudinal follow-up study.
    Modoni A; Silvestri G; Vita MG; Quaranta D; Tonali PA; Marra C
    J Neurol; 2008 Nov; 255(11):1737-42. PubMed ID: 18821050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive, neuropsychological and emotional-behavioural functioning in a sample of children with myotonic dystrophy type 1.
    Ricci FS; Vacchetti M; Brusa C; D'Alessandro R; La Rosa P; Martone G; Davico C; Vitiello B; Mongini TE
    Eur J Paediatr Neurol; 2022 Jul; 39():59-64. PubMed ID: 35679764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognition in myotonic dystrophy type 1: a 5-year follow-up study.
    Winblad S; Samuelsson L; Lindberg C; Meola G
    Eur J Neurol; 2016 Sep; 23(9):1471-6. PubMed ID: 27323306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneity of cognitive impairments in myotonic dystrophy type 1 explained by three distinct cognitive profiles.
    Davion JB; Tard C; Fragoso L; Wilu-Wilu A; Skrobala E; Defebvre L; Delbeuck X
    J Neurol; 2024 Jul; 271(7):4529-4539. PubMed ID: 38709306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frontostriatal dysexecutive syndrome: a core cognitive feature of myotonic dystrophy type 2.
    Peric S; Mandic-Stojmenovic G; Stefanova E; Savic-Pavicevic D; Pesovic J; Ilic V; Dobricic V; Basta I; Lavrnic D; Rakocevic-Stojanovic V
    J Neurol; 2015 Jan; 262(1):142-8. PubMed ID: 25346064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the pattern of cognitive impairment in myotonic dystrophy type 1.
    Modoni A; Silvestri G; Pomponi MG; Mangiola F; Tonali PA; Marra C
    Arch Neurol; 2004 Dec; 61(12):1943-7. PubMed ID: 15596617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brief assessment of cognitive function in myotonic dystrophy: Multicenter longitudinal study using computer-assisted evaluation.
    Deutsch GK; Hagerman KA; Sampson J; Dent G; Dekdebrun J; Parker DM; Thornton CA; Heatwole CR; Subramony SH; Mankodi AK; Ashizawa T; Statland JM; Arnold WD; Moxley RT; Day JW;
    Muscle Nerve; 2022 May; 65(5):560-567. PubMed ID: 35179228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive decline over time in adults with myotonic dystrophy type 1: A 9-year longitudinal study.
    Gallais B; Gagnon C; Mathieu J; Richer L
    Neuromuscul Disord; 2017 Jan; 27(1):61-72. PubMed ID: 27919548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropsychological Assessment Should Always be Considered in Myotonic Dystrophy Type 2.
    Theodosiou T; Christidi F; Xirou S; Bede P; Karavasilis E; Papadopoulos C; Kourtesis P; Pantoleon V; Kararizou E; Papadimas G; Zalonis I
    Cogn Behav Neurol; 2021 Mar; 34(1):1-10. PubMed ID: 33652465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal study in patients with myotonic dystrophy type 1: correlation of brain MRI abnormalities with cognitive performances.
    Cabada T; Díaz J; Iridoy M; López P; Jericó I; Lecumberri P; Remirez B; Seijas R; Gomez M
    Neuroradiology; 2021 Jul; 63(7):1019-1029. PubMed ID: 33237431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive impairment in adult myotonic dystrophies: a longitudinal study.
    Sansone V; Gandossini S; Cotelli M; Calabria M; Zanetti O; Meola G
    Neurol Sci; 2007 Mar; 28(1):9-15. PubMed ID: 17385090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clusters of cognitive impairment among different phenotypes of myotonic dystrophy type 1 and type 2.
    Peric S; Rakocevic Stojanovic V; Mandic Stojmenovic G; Ilic V; Kovacevic M; Parojcic A; Pesovic J; Mijajlovic M; Savic-Pavicevic D; Meola G
    Neurol Sci; 2017 Mar; 38(3):415-423. PubMed ID: 27896491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterizing cognitive-motor impairments in patients with myotonic dystrophy type 1.
    Filli L; Schwegler S; Meyer C; Killeen T; Easthope CS; Broicher SD; Curt A; Zörner B; Bolliger M; Jung HH; Petersen JA
    Neuromuscul Disord; 2020 Jun; 30(6):510-520. PubMed ID: 32527589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disease awareness in myotonic dystrophy type 1: an observational cross-sectional study.
    Baldanzi S; Bevilacqua F; Lorio R; Volpi L; Simoncini C; Petrucci A; Cosottini M; Massimetti G; Tognoni G; Ricci G; Angelini C; Siciliano G
    Orphanet J Rare Dis; 2016 Apr; 11():34. PubMed ID: 27044540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tracking the brain in myotonic dystrophies: A 5-year longitudinal follow-up study.
    Gliem C; Minnerop M; Roeske S; Gärtner H; Schoene-Bake JC; Adler S; Witt JA; Hoffstaedter F; Schneider-Gold C; Betz RC; Helmstaedter C; Tittgemeyer M; Amunts K; Klockgether T; Weber B; Kornblum C
    PLoS One; 2019; 14(3):e0213381. PubMed ID: 30845252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychological characteristics of patients with myotonic dystrophy type 1.
    Bertrand JA; Jean S; Laberge L; Gagnon C; Mathieu J; Gagnon JF; Richer L
    Acta Neurol Scand; 2015 Jul; 132(1):49-58. PubMed ID: 25496310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive Decline and White Matter Integrity Degradation in Myotonic Dystrophy Type I.
    Lopez-Titla MM; Chirino A; Cruz Solis SV; Hernandez-Castillo CR; Diaz R; Márquez-Quiroz LDC; Magaña JJ; Beltrán-Parrazal L; Fernandez-Ruiz J
    J Neuroimaging; 2021 Jan; 31(1):192-198. PubMed ID: 32936994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome Measures for Central Nervous System Evaluation in Myotonic Dystrophy Type 1 May Be Confounded by Deficits in Motor Function or Insight.
    Hamilton MJ; McLean J; Cumming S; Ballantyne B; McGhie J; Jampana R; Longman C; Evans JJ; Monckton DG; Farrugia ME
    Front Neurol; 2018; 9():780. PubMed ID: 30333784
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.